KVUE:NYSEKenvue Inc. Analysis
Data as of 2026-07-22 - not real-time
$19.19
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
KVUE is trading at $19.19, marginally above its 20‑day SMA (19.17) and comfortably above the 50‑day (18.22) and 200‑day (17.41) averages, confirming a short‑term bullish bias. The RSI sits at 56.7, indicating neutral momentum, while the MACD histogram is negative and the signal line is bearish, suggesting that upward momentum may be waning. Volume has been decreasing, and the 30‑day volatility of 22.5% is relatively high for a consumer‑defensive name, though the stock’s beta of 0.13 points to minimal market‑wide risk. The dividend yield of 4.37% is attractive, but the payout ratio of 98.5% raises sustainability concerns.
Fundamentally, KVUE posted 4.5% revenue growth, solid gross (58.6%) and operating (21.6%) margins, and a 15.7% ROE, yet carries a high net‑debt load (debt‑to‑equity 83) and a DCF‑derived fair value of $11.19, implying the market is pricing significant acquisition‑related premium. The announced $48.7 billion Kimberly‑Clark takeover has lifted the stock 14.5% over the past month, but analysts remain mixed, with a consensus “hold” and a modest 2.95% upside versus current price. These dynamics suggest that while the stock offers a strong dividend and defensive positioning, upside may be limited until the deal closes and integration risks are resolved.
Fundamentally, KVUE posted 4.5% revenue growth, solid gross (58.6%) and operating (21.6%) margins, and a 15.7% ROE, yet carries a high net‑debt load (debt‑to‑equity 83) and a DCF‑derived fair value of $11.19, implying the market is pricing significant acquisition‑related premium. The announced $48.7 billion Kimberly‑Clark takeover has lifted the stock 14.5% over the past month, but analysts remain mixed, with a consensus “hold” and a modest 2.95% upside versus current price. These dynamics suggest that while the stock offers a strong dividend and defensive positioning, upside may be limited until the deal closes and integration risks are resolved.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Acquisition premium already priced in
- Bearish MACD signal despite price above short‑term averages
- High dividend payout ratio may limit cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Potential synergies from Kimberly‑Clark integration
- Forward PE of 15.5 suggests value relative to earnings growth
- Moderate debt load could constrain flexibility
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic fit may improve margins and cash flow
- Defensive consumer‑health exposure supports stability
- Attractive dividend yield if payout ratio normalizes
Key Metrics & Analysis
Financial Health
Revenue Growth4.50%
Profit Margin10.61%
P/E Ratio22.8
ROE15.70%
ROA7.07%
Debt/Equity82.97
P/B Ratio3.5
Op. Cash Flow$2.3B
Free Cash Flow$1.9B
Technical Analysis
TrendBullish
RSI56.7
Support$18.46
Resistance$20.13
MA 20$19.17
MA 50$18.22
MA 200$17.41
MACDBearish
VolumeDecreasing
Fear & Greed Index91.5
Valuation
Fair Value$11.19
Target Price$19.75
Upside/Downside2.95%
GradeFair
TypeBlend
Dividend Yield4.37%
Risk Assessment
Beta0.13
Volatility22.54%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
6752
Panasonic Holdings Corporation
STOCK600018
Shanghai International Port (Group) Co., Ltd. Class A
STOCKEPIBX
EuroPac International Bond Fund
MUTUAL_FUNDWTFCN
Wintrust Financial Corporation - Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 7.875% Fixed-Rate Reset Non-Cumulative Perpetual Prefer
STOCKWENN
Wen Acquisition Corp
STOCKWCC
WESCO International, Inc.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.